Insider sale by Cerus COO shows routine portfolio moves, not distress, with other execs buying and strong pathogen‑inactivation tech keeping investor confidence high.
Jensen Chrystal’s March 2026 sale of 113k Cerus shares, tied to RSU vesting and tax plans, signals routine liquidity management rather than a bearish outlook.